Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells
Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells作者机构:National Institute of Diagnostics and Vaccine Development in Infectious DiseasesState Key Laboratory of Molecular Vaccinology and Molecular DiagnosticsSchool of Public Health&School of Life ScienceXiamen UniversityXiamen 361102China Biosafety Level-3 LaboratorySchool of Public HealthSouthern Medical UniversityGuangzhou 510515China
出 版 物:《Virologica Sinica》 (中国病毒学(英文版))
年 卷 期:2022年第37卷第4期
页 面:619-622页
核心收录:
学科分类:0710[理学-生物学] 1001[医学-基础医学(可授医学、理学学位)] 100102[医学-免疫学] 10[医学]
基 金:the National Natural Science Foundation of China(31870925) Shenzhen Science and Technology Innovation Commission for Research and Development Project(JCYJ20190809183205622) Guangdong Basic and Applied Basic Research Foundation(2020A1515010368)。
主 题:influenza activation globally
摘 要:Dear Editor,Influenza B viruses(IBVs)have circulated among humans for more than 80 years.Seasonal influenza virus epidemics caused by two IBV lines(Victoria and Yamagata)and influenza A virus have considerable effects on public health globally and result in approximately290,000–650,000 annual influenza-attributed deaths(Caini et al.,2015;Pan et al.,2015).Currently,the most effective countermeasures against influenza B virus infections are influenza virus vaccines(Subbarao and Matsuoka,2013).However,these vaccines have limited efficacy because only strain-matched humoral immune responses are induced.